![](../../files/images/goods/173528-92-2.png)
HMN-154
CAS No. 173528-92-2
HMN-154 ( HMN-154; HMN 154; HMN154 )
Catalog No. M17368 CAS No. 173528-92-2
HMN-154 is a novel benzenesulfonamide anticancer compound.
Purity : 98%
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
Size | Price / USD | Stock | Quantity |
2MG | 133 | In Stock |
![]() ![]() |
5MG | 244 | In Stock |
![]() ![]() |
10MG | 368 | In Stock |
![]() ![]() |
25MG | 478 | In Stock |
![]() ![]() |
50MG | 587 | In Stock |
![]() ![]() |
100MG | 696 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHMN-154
-
NoteResearch use only, not for human use.
-
Brief DescriptionHMN-154 is a novel benzenesulfonamide anticancer compound.
-
DescriptionHMN-154 is a benzenesulfonamide anticancer agent. HMN-154 inhibits DNA binding of NF-Y to the human major histocompatibility complex class II human leukocyte antigen DRA Y-box sequence in a dose-dependent manner.
-
SynonymsHMN-154; HMN 154; HMN154
-
PathwayTyrosine Kinase
-
TargetTAM Receptor
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number173528-92-2
-
Formula Weight366.44
-
Molecular FormulaC20H18N2O3S
-
Purity98%
-
Solubility——
-
SMILESc1(c(cccc1)/C=C/c1ccncc1)NS(=O)(=O)c1ccc(cc1)OC
-
Chemical Name(E)-4-(2-(2-(N-(4-Methoxybenzenesulfonyl)amino)phenyl)ethenyl)pyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tanaka H., et al. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol Pharmacol. 1999 Feb;55(2):356-63.
molnova catalog
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/ct2.png)
related products
-
Ningetinib Tosylate
Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.
-
Sodium Picosulfate
Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
-
ONO-7475
ONO-7475?is an inhibitor with high specificity for anexelekto and MER tyrosine kinase.